RGEN Competitors & Alternatives
Compare Repligen Corp with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
RGEN
Main Stock$111.49
Tradestie Score
57
Market Cap
$8.20B
P/E Ratio
128.0
Revenue Growth
0.2%
Analyst Upside
+67.6%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$349.00
|
$160.70B | 24.5 | 58 | Compare |
|
GILD
Gilead Sciences Inc
|
$136.34
|
$137.92B | 19.8 | 56 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$704.31
|
$46.96B | 35.3 | 61 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$85.25
|
$24.57B | - | 48 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$187.57
|
$22.61B | 20.9 | 64 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$128.72
|
$13.59B | 27.5 | 63 | Compare |
|
EXEL
Exelixis Inc
|
$41.95
|
$11.09B | 14.9 | 62 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$48.23
|
$10.74B | - | 53 | Compare |
|
QGEN
QIAGEN N.V.
|
$39.32
|
$10.04B | 19.2 | 54 | Compare |
|
TECH
Bio-Techne Corp.
|
$52.04
|
$9.33B | 96.1 | 55 | Compare |
More RGEN Analysis
Data updated: Mar 30, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry